A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics

R. S. Blank, E. A. Swartz, M. M. Thompson, E. N. Olson, G. K. Owens

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Despite intense interest in understanding the differentiation of vascular smooth muscle, very little is known about the cellular and molecular mechanisms that control differentiation of this cell type. Progress in this field has been hampered by the lack of an inducible in vitro system for study of the early steps of smooth muscle differentiation. In this study, we describe a model system in which multipotential mouse P19 embryonal carcinoma cells (P19s) can be induced to express multiple characteristics of differentiated smooth muscle. Treatment of P19s with retinoic acid was associated with profound changes in cell morphology and with the appearance at high frequency of smooth muscle α-actin-positive cells that were absent or present at extremely low frequency in parental P19s. A clonal line derived from retinoic acid-treated P19s (9E11G) stably expressed multiple characteristics of differentiated smooth muscle, including smooth muscle specific isoforms of α-actin and myosin heavy chain, as well as functional responses to the contractile agonists phenylephrine, angiotensin II, ATP, bradykinin, histamine, platelet-derived growth factor (PDGF)-AA, and PDGF- BB. Additionally, 9E11G cells expressed transcripts for MHox, a muscle homeobox gene expressed in smooth, cardiac, and skeletal muscles, but not the skeletal muscle-specific regulatory factors, MyoD and myogenin. Results demonstrate that retinoic acid treatment of multipotential P19 cells is associated with formation of cell lines that stably express multiple properties of differentiated smooth muscle. It remains to be determined whether retinoic acid has induced commitment to a smooth muscle cell lineage as opposed to directly (or indirectly) activating genes characteristic of differentiated smooth muscle cells. However, results suggest that this cell system may be of use in attempting to identify genes involved in controlling smooth muscle differentiation and/or lineage determination.

Original languageEnglish (US)
Pages (from-to)742-749
Number of pages8
JournalCirculation Research
Volume76
Issue number5
StatePublished - 1995

Fingerprint

Embryonal Carcinoma Stem Cells
Tretinoin
Smooth Muscle
Cell Line
Smooth Muscle Myocytes
Actins
Skeletal Muscle
MyoD Protein
Myogenin
Myosin Heavy Chains
Homeobox Genes
Platelet-Derived Growth Factor
Bradykinin
Phenylephrine
Cell Lineage
Vascular Smooth Muscle
Angiotensin II
Histamine
Genes
Cell Differentiation

Keywords

  • embryonal carcinoma cells
  • homeobox genes
  • muscle-specific gene expression
  • smooth muscle differentiation
  • transcription factors

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics. / Blank, R. S.; Swartz, E. A.; Thompson, M. M.; Olson, E. N.; Owens, G. K.

In: Circulation Research, Vol. 76, No. 5, 1995, p. 742-749.

Research output: Contribution to journalArticle

@article{b5e8d7668f7f4a75a2417cceb1a9a8db,
title = "A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics",
abstract = "Despite intense interest in understanding the differentiation of vascular smooth muscle, very little is known about the cellular and molecular mechanisms that control differentiation of this cell type. Progress in this field has been hampered by the lack of an inducible in vitro system for study of the early steps of smooth muscle differentiation. In this study, we describe a model system in which multipotential mouse P19 embryonal carcinoma cells (P19s) can be induced to express multiple characteristics of differentiated smooth muscle. Treatment of P19s with retinoic acid was associated with profound changes in cell morphology and with the appearance at high frequency of smooth muscle α-actin-positive cells that were absent or present at extremely low frequency in parental P19s. A clonal line derived from retinoic acid-treated P19s (9E11G) stably expressed multiple characteristics of differentiated smooth muscle, including smooth muscle specific isoforms of α-actin and myosin heavy chain, as well as functional responses to the contractile agonists phenylephrine, angiotensin II, ATP, bradykinin, histamine, platelet-derived growth factor (PDGF)-AA, and PDGF- BB. Additionally, 9E11G cells expressed transcripts for MHox, a muscle homeobox gene expressed in smooth, cardiac, and skeletal muscles, but not the skeletal muscle-specific regulatory factors, MyoD and myogenin. Results demonstrate that retinoic acid treatment of multipotential P19 cells is associated with formation of cell lines that stably express multiple properties of differentiated smooth muscle. It remains to be determined whether retinoic acid has induced commitment to a smooth muscle cell lineage as opposed to directly (or indirectly) activating genes characteristic of differentiated smooth muscle cells. However, results suggest that this cell system may be of use in attempting to identify genes involved in controlling smooth muscle differentiation and/or lineage determination.",
keywords = "embryonal carcinoma cells, homeobox genes, muscle-specific gene expression, smooth muscle differentiation, transcription factors",
author = "Blank, {R. S.} and Swartz, {E. A.} and Thompson, {M. M.} and Olson, {E. N.} and Owens, {G. K.}",
year = "1995",
language = "English (US)",
volume = "76",
pages = "742--749",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics

AU - Blank, R. S.

AU - Swartz, E. A.

AU - Thompson, M. M.

AU - Olson, E. N.

AU - Owens, G. K.

PY - 1995

Y1 - 1995

N2 - Despite intense interest in understanding the differentiation of vascular smooth muscle, very little is known about the cellular and molecular mechanisms that control differentiation of this cell type. Progress in this field has been hampered by the lack of an inducible in vitro system for study of the early steps of smooth muscle differentiation. In this study, we describe a model system in which multipotential mouse P19 embryonal carcinoma cells (P19s) can be induced to express multiple characteristics of differentiated smooth muscle. Treatment of P19s with retinoic acid was associated with profound changes in cell morphology and with the appearance at high frequency of smooth muscle α-actin-positive cells that were absent or present at extremely low frequency in parental P19s. A clonal line derived from retinoic acid-treated P19s (9E11G) stably expressed multiple characteristics of differentiated smooth muscle, including smooth muscle specific isoforms of α-actin and myosin heavy chain, as well as functional responses to the contractile agonists phenylephrine, angiotensin II, ATP, bradykinin, histamine, platelet-derived growth factor (PDGF)-AA, and PDGF- BB. Additionally, 9E11G cells expressed transcripts for MHox, a muscle homeobox gene expressed in smooth, cardiac, and skeletal muscles, but not the skeletal muscle-specific regulatory factors, MyoD and myogenin. Results demonstrate that retinoic acid treatment of multipotential P19 cells is associated with formation of cell lines that stably express multiple properties of differentiated smooth muscle. It remains to be determined whether retinoic acid has induced commitment to a smooth muscle cell lineage as opposed to directly (or indirectly) activating genes characteristic of differentiated smooth muscle cells. However, results suggest that this cell system may be of use in attempting to identify genes involved in controlling smooth muscle differentiation and/or lineage determination.

AB - Despite intense interest in understanding the differentiation of vascular smooth muscle, very little is known about the cellular and molecular mechanisms that control differentiation of this cell type. Progress in this field has been hampered by the lack of an inducible in vitro system for study of the early steps of smooth muscle differentiation. In this study, we describe a model system in which multipotential mouse P19 embryonal carcinoma cells (P19s) can be induced to express multiple characteristics of differentiated smooth muscle. Treatment of P19s with retinoic acid was associated with profound changes in cell morphology and with the appearance at high frequency of smooth muscle α-actin-positive cells that were absent or present at extremely low frequency in parental P19s. A clonal line derived from retinoic acid-treated P19s (9E11G) stably expressed multiple characteristics of differentiated smooth muscle, including smooth muscle specific isoforms of α-actin and myosin heavy chain, as well as functional responses to the contractile agonists phenylephrine, angiotensin II, ATP, bradykinin, histamine, platelet-derived growth factor (PDGF)-AA, and PDGF- BB. Additionally, 9E11G cells expressed transcripts for MHox, a muscle homeobox gene expressed in smooth, cardiac, and skeletal muscles, but not the skeletal muscle-specific regulatory factors, MyoD and myogenin. Results demonstrate that retinoic acid treatment of multipotential P19 cells is associated with formation of cell lines that stably express multiple properties of differentiated smooth muscle. It remains to be determined whether retinoic acid has induced commitment to a smooth muscle cell lineage as opposed to directly (or indirectly) activating genes characteristic of differentiated smooth muscle cells. However, results suggest that this cell system may be of use in attempting to identify genes involved in controlling smooth muscle differentiation and/or lineage determination.

KW - embryonal carcinoma cells

KW - homeobox genes

KW - muscle-specific gene expression

KW - smooth muscle differentiation

KW - transcription factors

UR - http://www.scopus.com/inward/record.url?scp=0028937242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028937242&partnerID=8YFLogxK

M3 - Article

C2 - 7728990

AN - SCOPUS:0028937242

VL - 76

SP - 742

EP - 749

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 5

ER -